Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biogen Inc. buy Oppenheimer Holdings Inc.

Start price
€208.60
14.02.24 / 50%
Target price
€270.25
14.02.25
Performance (%)
-35.88%
End price
€133.75
15.02.25
Summary
This prediction ended on 15.02.25 with a price of €133.75. The BUY prediction by Oppenheimer_Holdings for Biogen Inc. performed very badly with a performance of -35.88%. Oppenheimer_Holdings has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Biogen Inc. -3.568% -3.568% 1.920%
iShares Core DAX® 0.060% 1.215% 18.128%
iShares Nasdaq 100 -3.065% -0.519% 2.080%
iShares Nikkei 225® -2.094% -3.066% 11.655%
iShares S&P 500 -1.657% -0.069% 1.103%

Comments by Oppenheimer_Holdings for this prediction

In the thread Biogen Inc. diskutieren
Prediction Buy
Perf. (%) -35.88%
Target price 270.251
Change
Ends at 14.02.25

Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $295.00 to $290.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat

In the thread Trading Biogen Inc.
Prediction Buy
Perf. (%) -35.88%
Target price 270.251
Change
Ends at 14.02.25

Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Oppenheimer_Holdings for Biogen Inc.

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€160.90
31.10.24
€234.50
31.10.25
-16.25%
01.11.25

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€201.10
29.04.24
€251.56
29.04.25
-47.29%
30.04.25

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€227.80
30.01.24
€272.17
30.01.25
-38.10%
31.01.25

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€228.00
18.12.23
€269.93
18.12.24
-38.27%
19.12.24